(GS02) Expertise in Action—Disruptive Innovations to Advance Diabetes Care

Saturday, August 8, 2026

8:00 AM - 9:00 AM ET

CE: 1.0 CE

Stakeholder engagement is not a buzzword—it is the bridge between innovation and impact. In her keynote, Dr. Sherita Golden will share her journey from “Queen Esther” moments in Baltimore following the death of Freddie Gray to leading system-level change in COVID-19 and diabetes care. She will highlight academic–community partnerships that successfully delivered the Diabetes Prevention Program (DPP), including AI-supported coaching, as well as emerging data on diabetes and brain health from the DPP follow-up study, DPPOS. Through patient stories and research innovation, she will challenge us to design diabetes programs that truly reach all, including aging adults, people with disabilities, rural communities, and those living in poverty.

Disclosure(s):

Sherita H. Golden, MD, MHS, FAHA: Abbott Diabetes Care, Inc.: Consultant / Advisory Board (Ongoing); Genentech: Consultant / Advisory Board (Terminated, October 1, 2024); Novo Nordisk: Consultant / Advisory Board (Terminated, October 1, 2025)

Keynote Speaker(s)

Sherita H. Golden, MD, MHS, FAHA

Hugh P. McCormick Family Professor of Endocrinology and Metabolism, Vice President and Chief Diversity Officer
Johns Hopkins Medicine

Disclosure(s): Abbott Diabetes Care, Inc.: Consultant / Advisory Board (Ongoing); Genentech: Consultant / Advisory Board (Terminated, October 1, 2024); Novo Nordisk: Consultant / Advisory Board (Terminated, October 1, 2025)